Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;36(10):3289-3291.
doi: 10.1007/s11606-021-07057-0. Epub 2021 Aug 3.

Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection

Juan P Wisnivesky  1   2 , Kimberly Stone  3 , Emilia Bagiella  4 , Molly Doernberg  3 , Damodara Rao Mendu  5 , Jenny J Lin  3 , Minal Kale  3
Affiliations

Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection

Juan P Wisnivesky et al. J Gen Intern Med. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Juan Wisnivesky has received consulting honoraria from Sanofi, GSK, Banook, and Atea and research grants from Sanofi, Regeneron, and Arnold Consultants. Other authors report no conflict of interests.

Figures

Figure 1
Figure 1
Adjusted predicted probability of positive neutralizing antibody test over time according to site of acute care. Rates of positive antibody test against SARS-CoV-2 remained high up to 13 months post-COVID-19. Patients treated in the hospital had significant higher rates of positive results compared to those who were managed in the outpatient setting. There were no significant differences among patients treated in the emergency department or managed as outpatients for acute COVID-19.
See this image and copyright information in PMC

References

    1. Lee WT, Girardin RC, Dupuis AP, et al. Neutralizing Antibody Responses in COVID-19 Convalescent Sera. J Infect Dis. Published online October 26, 2020. doi:10.1093/infdis/jiaa673 - PMC - PubMed
    1. Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J Med. 2020;383(11):1085–1087. doi: 10.1056/NEJMc2025179. - DOI - PMC - PubMed
    1. Ripperger TJ, Uhrlaub JL, Watanabe M, et al. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity. Immunity. 2020;53(5):925–933.e4. doi: 10.1016/j.immuni.2020.10.004. - DOI - PMC - PubMed
    1. Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227–1230. doi: 10.1126/science.abd7728. - DOI - PMC - PubMed
    1. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. Published online April 22, 2021:1-8. doi:10.1038/s41586-021-03553-9 - PubMed